On Monday, Shares of Eli Lilly and Co (NYSE:LLY), added 1.18% and closed at $83.06 in the last trading session. The last trading range of the stock ranges between $82.10 and $83.24. The company’s Market capitalization is $92.38 Billion with the total Outstanding Shares of 1.10 billion. Important clinical study results from one of Eli Lilly and Company’s (LLY) ongoing immuno-oncology collaborations with Merck (known as MSD outside the U.S. and Canada) were declared recently at the ESMO 2016 Congress, the annual meeting of the European Society for Medical Oncology. Specifically, data released from KEYNOTE-021, Cohort G, which evaluated ALIMTA® (pemetrexed) plus carboplatin in combination with Merck’s KEYTRUDA® (pembrolizumab) in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC), showed that the combination of ALIMTA, KEYTRUDA and carboplatin demonstrated superior efficacy contrast to ALIMTA and carboplatin – standard of care – alone.
In KEYNOTE-021, Cohort G, which included patients with advanced nonsquamous NSCLC regardless of PD-L1 expression level, the combination of pemetrexed, pembrolizumab and carboplatin achieved a 55 percent objective response rate (ORR) contrast to 29 percent for pemetrexed-plus-carboplatin alone, and reduced the risk of disease progression or death by 47 percent. Median progression-free survival (PFS) was 13.0 months with the pemetrexed-pembrolizumab-carboplatin combination. To date, this combination of pemetrexed-pembrolizumab-carboplatin is the only anti-PD-1-containing regimen to demonstrate superior efficacy contrast to chemotherapy alone in NSCLC patients receiving first-line treatment.
“These randomized study data of ALIMTA and KEYTRUDA in first-line nonsquamous non-small cell lung cancer build on the early results we’ve seen in this combination and are very encouraging,” said Richard Gaynor, M.D., senior vice president, product development and medical affairs for Lilly Oncology. “To see a near-doubling in the number of patients responding to this combination gives us hope for what may be able to be achieved above and beyond what is seen with the ALIMTA-containing standard-of-care regimen. These types of clinical advancements are truly exciting as we continue our pursuit to bring meaningful benefits to patients facing cancer.”
Deere & Company (NYSE:DE), jumped 1.38% and closed at $87.49 in the last trading session. The last trading range of the stock ranges between $87.30 and $89.34. The company’s Market capitalization is $27.83 Billion with the total Outstanding Shares of 536.43 million. During the 52-week trading session the minimum price at which share price traded, registered at $70.16 and reached to max level of $89.34. Deere & Company, together with its auxiliaries, manufactures and distributes agriculture and turf, and construction and forestry equipment worldwide. The companys Agriculture and Turf segment provides agriculture and turf equipment, and related service parts, counting large, medium, and utility tractors; loaders; combines, corn pickers, cotton and sugarcane harvesters, and related front-end equipment and sugarcane loaders; and tillage, seeding, and application equipment, counting sprayers, nutrient administration, and soil preparation machinery. This segment also provides hay and forage equipment comprising self-propelled forage harvesters and attachments, balers, and mowers; turf and utility equipment, counting riding lawn equipment and walk-behind mowers, golf course equipment, utility vehicles, and commercial mowing equipment, in addition to associated implements; integrated agricultural administration systems technology and solutions; and other outdoor power products. Its Construction and Forestry segment provides backhoe loaders; crawler dozers and loaders; four-wheel-drive loaders; excavators; motor graders; articulated dump trucks; landscape loaders; skid-steer loaders; and log skidders, feller bunchers, log loaders, log forwarders, log harvesters, and related attachments that are used in construction, earthmoving, material handling, and timber harvesting applications.
On the otherhand Newell Brands Inc (NYSE:NWL), dropped -1.10% and closed at $51.34 in the last trading session. The last trading range of the stock ranges between $51.32 and $52.43. The company’s Market capitalization is $24.56 Billion with the total Outstanding Shares of 482.20 million. During the 52-week trading session the minimum price at which share price traded, registered at $33.26 and reached to max level of $55.45. Jostens, the leading provider of high-end custom jewelry for professional sports teams, unveiled the National Hockey League’s 2016 Stanley Cup championship rings recently, when the Pittsburgh Penguins presented the rings to players, coaches and hockey staff during a private ceremony at the Heinz History Center.
The rings commemorate the Penguins’ outstanding 2015-2016 season and celebrate the team’s triumphant victory in the Stanley Cup championship on June 12.
“These unique and brilliant rings will always be an inspiring symbol of what our players and coaches accomplished by winning the Stanley Cup,” said David Morehouse, president and CEO of the Pittsburgh Penguins. “On behalf of our owners, Mario Lemieux and Ron Burkle, in addition to our players and coaches, I want to thank Jostens for the creativity and craftsmanship that went into this very special Stanley Cup championship ring project.”
“Jostens is honored to once again partner with the Penguins to create a championship ring that celebrates the team’s championship history,” said Chris Poitras, Jostens division vice president of professional sports. “This one-of-a-kind ring is hand crafted and features over 300 diamonds totaling almost 9 brilliant carats.”
The Penguins’ Stanley Cup Championship Ring is crafted in white gold, while “STANLEY CUP CHAMPION”‘ frames the top and bottom edges of the ring in yellow gold. This dual-tone technique creates a brilliant display of contrast.